Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$40.89 – $54.63
98% from low
Exchange
ARCX
ETF
No company description on file.
No one on the platform currently holds PVAL.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 29,100 | $1.4M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-07 | $0.1264 | 2026-07-14 |
| 2026-04-07 | $0.1405 | 2026-04-14 |
| 2025-12-19 | $0.1124 | 2025-12-23 |
| 2025-10-06 | $0.1029 | 2025-10-08 |
| 2025-07-07 | $0.1400 | 2025-07-09 |
| 2025-04-04 | $0.1010 | 2025-04-08 |
| 2024-12-05 | $0.1546 | 2024-12-09 |
| 2024-09-06 | $0.1210 | 2024-09-10 |
| 2024-06-06 | $0.1110 | 2024-06-10 |
| 2024-03-06 | $0.1110 | 2024-03-11 |
No one on the platform has traded PVAL yet.
| 2023-12-06 | $0.2118 | 2023-12-11 |
| 2023-09-07 | $0.1110 | 2023-09-12 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PVALPutnam Focused Large Cap Value ETF | $54.42 | +0.04% | $5.8B | — |
| BKLCBNY Mellon US Large Cap Core Equity ETF | $49.73 | +0.63% | $5.7B | — |
| DIHPDimensional International High Profitability ETF | $35.60 | -0.01% | $6.4B | — |
| EEMViShares MSCI Emerging Markets Min Vol Factor ETF | $74.81 | +0.23% | $3.6B | — |
| FELGFidelity Enhanced Large Cap Growth ETF | $45.05 | +1.12% | $6.0B | — |
| GSIEGoldman Sachs ActiveBeta International Equity ETF | $48.25 | +0.22% | $6.0B | — |
| IVOOVanguard S&P Mid-Cap 400 ETF | $132.63 | +0.37% | $6.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
NVO Stock Jumps 3% As EU Approves Oral Wegovy Pill — Retail Notes LLY Is ‘Clearly Behind’ Its Danish Counterpart $NVO $PVAL $AVDE $LLY https://stocktwits.com/news/equity/markets/nvo-stock-jumps-3-as-eu-approves-oral-wegovy-pill-retail-notes-lly-is-clearly-behind-its-danish-counterpart/cZZPaw9R7r9
View on StockTwits ↗NVO Stock Gains As UK Clears First Daily GLP-1 Weight-Loss Pill, Offsetting Security Breach News $NVO $PVAL $PPH https://stocktwits.com/news/equity/markets/nvo-stock-gains-as-uk-clears-first-daily-glp-1-weight-loss-pill-offsetting-security-breach-news/cZKTzonR72u
View on StockTwits ↗AZN Stock Rise As Wall Street Dismisses FDA Committee’s Rejection Of Breast Cancer Drug $AZN $PVAL $AVDE https://stocktwits.com/news/equity/markets/azn-stock-rise-as-wall-street-dismisses-fda-commitees-rejection-of-breast-cancer-drug/cZBMnogReIf
View on StockTwits ↗Novo Nordisk Launches Higher Dose Of Wegovy Injection Across US — Retail Thinks Stock Is ‘Terribly Undervalued’ $NVO $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-launches-higher-dose-of-wegovy-injection-across-us/cZJJyAuRIpU
View on StockTwits ↗Novo Nordisk Receives FDA Approval For Higher Dose Of Its Weight-Loss Drug Wegovy $NVO $PPH $PVAL https://stocktwits.com/news/equity/markets/novo-nordisk-wegovy-hd-7-2-mg-approved-by-fda/cZ3aFJgRIhX
View on StockTwits ↗Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-hims-deal-turns-wall-street-bullish-hims-stock-upgrades/cZdos7IRI7d
View on StockTwits ↗HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy $HIMS $NVO $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/hims-stock-soars-novo-nordisk-drops-patent-suit-hims-hers-partnership-ozempic/cZdVZe7RIIk
View on StockTwits ↗Why Is NVO Stock Falling Pre-Market Today? $NVO $PPH $PVAL $AVDE $FTHI https://stocktwits.com/news/equity/markets/why-is-nvo-stock-falling-pre-market-today/cZRtZlKR4UC
View on StockTwits ↗Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly $NVO $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-reportedly-eyes-launching-wegovy-in-vials/cZb6rpcR4A0
View on StockTwits ↗FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/fda-novo-wegovy-pill-tv-advertisement-misleading-nvo-stock-pares-gains/cZbv5uwR4oX
View on StockTwits ↗Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-sues-hims-hers-permanent-ban-unapproved-compounded-drugs/cZbHzMjR4o2
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.